Determination of thyrotropin reference values in an adult Mexican population

Endocrinologia y Nutricion

Volumn 62, Issue 2, 2015, Pages 56-63

  Flores Rebollar, Armando ^a   Moreno Castañeda, Lidia ^a   Vega Servín, Norman S ^a   López Carrasco, Guadalupe ^a   Ruiz Juvera, Aída ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID ANTIBODY; THYROID HORMONE; THYROTROPIN; AUTOANTIBODY; IODINE; THYROID MICROSOMAL ANTIBODIES;

ADMINISTRATIVE PERSONNEL; ADULT; ARTICLE; CORRELATIONAL STUDY; ECHOGRAPHY; FEMALE; HOSPITAL PERSONNEL; HUMAN; MALE; MEDICAL STAFF; MEXICO; PREVALENCE; QUESTIONNAIRE; REFERENCE VALUE; SEX DIFFERENCE; THYROID DISEASE; THYROID GLAND EXAMINATION; BLOOD; CROSS-SECTIONAL STUDY; DEFICIENCY; DIAGNOSTIC IMAGING; EPIDEMIOLOGY; IMMUNOLOGY; NORMAL HUMAN; PHYSICAL EXAMINATION; THYROID GLAND; URINE; YOUNG ADULT;

ADULT; AUTOANTIBODIES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTHY VOLUNTEERS; HUMANS; IODINE; MALE; MEXICO; PERSONNEL, HOSPITAL; PHYSICAL EXAMINATION; REFERENCE VALUES; THYROID GLAND; THYROID HORMONES; THYROTROPIN; YOUNG ADULT;

EID: 84921461003     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2014.10.003     Document Type: Article

References (30)

1. Wartofsky L., Dickey R.A. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005, 90:5483-5488.
2. Brabant G., Beck-Peccoz P., Jarzab B., Laurberg P., Orgiazzi J., Szabolcs I., et al. Is there a need to redefine the upper normal limit of TSH?. Eur J Endocrinol 2006, 154:633-637.
3. Surks M.I. Should the upper limit of the normal reference range for TSH be lowered?. Nat Clin Pract Endocrinol Metab 2008, 4:370-371.
4. Baloch Z., Carayon P., Conte-Devolx B., Demers L.M., Feldt-Rasmussen U., Henry J.F., et al. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13:3-126.
5. Vanderpump M.P. The epidemiology of thyroid disease. Br Med Bull 2011, 99:39-51.
6. Pedersen O.M., Aardal N.P., Larssen T.B., Varhaug J.E., Myking O., Vik-Mo H. The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid 2000, 10:251-259.
7. Camargo R.Y., Tomimori E.K., Neves S.C., Rubio G.S., Galrao A.L., Knobel M., et al. Thyroid and the environment: exposure to excessive nutritional iodine increases the prevalence of thyroid disorders in Sao Paulo, Brazil. Eur J Endocrinol 2008, 159:293-299.
8. Yoshihara A., Noh J.Y., Ohye H., Sato S., Sekiya K., Kosuga Y., et al. Reference limits for serum thyrotropin in a Japanese population. Endocr J 2011, 58:585-588.
9. Kutluturk F., Yildirim B., Ozturk B., Ozyurt H., Bekar U., Sahin S., et al. The reference intervals of thyroid stimulating hormone in healthy individuals with normal levels of serum free thyroxine and without sonographic pathologies. Endocr Res 2014, 39:56-60.
10. Zingrillo M., D'Aloiso L., Ghiggi M.R., Di C.A., Chiodini I., Torlontano M., et al. Thyroid hypoechogenicity after methimazole withdrawal in Graves' disease: a useful index for predicting recurrence?. Clin Endocrinol (Oxf) 1996, 45:201-206.
11. The theory of reference values. Part 5. Statistical treatment of collected reference values. Determination of reference limits. Clin Chim Acta 1984, 137:97F-114F. International Federation of Clinical Chemistry, Scientific Committee, Clinical Section, Expert Panel on Theory of Reference Values (EPTRV).
12. Sriphrapradang C., Pavarangkoon S., Jongjaroenprasert W., Chailurkit L., Ongphiphadhanakul B., Aekplakorn W. Reference ranges of serum TSH FT4 and thyroid autoantibodies in the Thai population: the national health examination survey. Clin Endocrinol (Oxf) 2014, 80:751-756.
13. World Health, Organization. Assessment of iodine deficiency disorders and monitoring their elimination 2007, WHO, Geneve. 3rd ed.
14. Teng W., Shan Z., Teng X., Guan H., Li Y., Teng D., et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med 2006, 354:2783-2793.
15. Teng X., Shan Z., Chen Y., Lai Y., Yu J., Shan L., et al. More than adequate iodine intake may increase subclinical hypothyroidism and autoimmune thyroiditis: a cross-sectional study based on two Chinese communities with different iodine intake levels. Eur J Endocrinol 2011, 164:943-950.
16. Shan Z.Y., Li Y.S., Wang Z.Y., Jin Y., Guan H.X., Hu F.N., et al. Effect of different iodine intake on the prevalence of hypothyroidism in 3 counties in China. Chin Med J (Engl) 2005, 118:1918-1920.
17. Li Y., Teng D., Shan Z., Teng X., Guan H., Yu X., et al. Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes. J Clin Endocrinol Metab 2008, 93:1751-1757.
18. Li C., Guan H., Teng X., Lai Y., Chen Y., Yu J., et al. An epidemiological study of the serum thyrotropin reference range and factors that influence serum thyrotropin levels in iodine sufficient areas of China. Endocr J 2011, 58:995-1002.
19. Guan H., Shan Z., Teng X., Li Y., Teng D., Jin Y., et al. Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes. Clin Endocrinol (Oxf) 2008, 69:136-141.
20. Papanastasiou L., Vatalas I.A., Koutras D.A., Mastorakos G. Thyroid autoimmunity in the current iodine environment. Thyroid 2007, 17:729-739.
21. Fountoulakis S., Philippou G., Tsatsoulis A. The role of iodine in the evolution of thyroid disease in Greece: from endemic goiter to thyroid autoimmunity. Hormones (Athens) 2007, 6:25-35.
22. Premawardhana L.D., Parkes A.B., Smyth P.P., Wijeyaratne C.N., Jayasinghe A., de Silva D.G., et al. Increased prevalence of thyroglobulin antibodies in Sri Lankan schoolgirls - is iodine the cause?. Eur J Endocrinol 2000, 143:185-188.
23. Boukis M.A., Koutras D.A., Souvatzoglou A., Evangelopoulou A., Vrontakis M., Moulopoulos S.D. Thyroid hormone and immunological studies in endemic goiter. J Clin Endocrinol Metab 1983, 57:859-862.
24. Zois C., Stavrou I., Kalogera C., Svarna E., Dimoliatis I., Seferiadis K., et al. High prevalence of autoimmune thyroiditis in schoolchildren after elimination of iodine deficiency in northwestern Greece. Thyroid 2003, 13:485-489.
25. Duarte G.C., Tomimori E.K., de Camargo R.Y., Catarino R.M., Ferreira J.E., Knobel M., et al. Excessive iodine intake and ultrasonographic thyroid abnormalities in schoolchildren. J Pediatr Endocrinol Metab 2009, 22:327-334.
26. Jensen E., Blaabjerg O., Petersen P.H., Hegedus L. Sampling time is important but may be overlooked in establishment and use of thyroid-stimulating hormone reference intervals. Clin Chem 2007, 53:355-356.
27. Rawlins M.L., Roberts W.L. Performance characteristics of six third-generation assays for thyroid-stimulating hormone. Clin Chem 2004, 50:2338-2344.
28. d'Herbomez M., Forzy G., Gasser F., Massart C., Beaudonnet A., Sapin R. Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations. Clin Chem Lab Med 2003, 41:942-947.
29. Ladenson P.W., Singer P.A., Ain K.B., Bagchi N., Bigos S.T., Levy E.G., et al. American Thyroid Association guidelines for detection of thyroid dysfunction. Arch Intern Med 2000, 160:1573-1575.
30. Zimmermann M.B., Andersson M. Update on iodine status worldwide. Curr Opin Endocrinol Diabetes Obes 2012, 19:382-387.